What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
CIK: 0002013334
Total reported value
$269.0M
$269.0M
12 檔
74.8%
During the Q4 2024 filing period, Zeno Equity Partners LLP (CIK: 0002013334) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $269.0M across 12 reported positions.
In Q4 2024, Zeno Equity Partners LLP adopted a defensive or profit-taking posture, trimming 4 positions and completely liquidating 5 holdings to manage risk exposure.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Waldencast PLC | Stock-Other | 18.49% | +3.30% | — | |
| 2 | DHR | Danaher CORP | Stock-Healthcare | 11.98% | -1.29% | +11.24% | |
| 3 | GE | General Electric | Stock-Industrials | 10.34% | — | -5.50% | |
| 4 | AMZN | Amazon.com Inc | Stock-Consumer Disc | 9.98% | -2.47% | +3.10% | |
| 5 | APPF | Appfolio Inc - A | Stock-Tech | 9.57% | — | -26.94% | |
| 6 | LIN | Linde plc | Stock-Materials | 9.34% | -1.40% | +3.82% | |
| 7 | DSGX | Descartes Systems Grp/the | Stock-Tech | 8.73% | -1.12% | -4.05% | |
| 8 | TXN | Texas Instruments Inc | Stock-Tech | 7.80% | — | -9.23% | |
| 9 | MEDP | Medpace Holdings Inc | Stock-Healthcare | 6.05% | — | +24.93% | |
| 10 | HEI-A | Heico Corp-class A | Stock-Other | 3.99% | +0.72% | +5.63% | |
| 11 | APH | Amphenol Corp-cl A | Stock-Tech | 3.41% | — | — | |
| 12 | ✓ | Waldencast PLC | Stock-Other | 0.32% | +0.02% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | APH | Amphenol Corp-cl A | +3.4% | NEW | New buy |
| 2 | ✓ | Waldencast PLC | +2.9% | — | Unchanged |
| 3 | AMZN | Amazon.com Inc | +2.3% | +3.10% | Add |
| 4 | MEDP | Medpace Holdings Inc | +1.5% | +24.93% | Add |
| 5 | DSGX | Descartes Systems Grp/the | +1.1% | -4.05% | Trim |
| 6 | HEI-A | Heico Corp-class A | +0.1% | +5.63% | Add |
| 7 | ✓ | Waldencast PLC | 0% | — | Unchanged |
| 8 | ✓ | Invesco QQQ Tr Put Option 06/2 | -0.1% | EXIT | Sold out |
| 9 | ✓ | Spdr S&P 500 Etf Tr Put Option | -0.1% | EXIT | Sold out |
| 10 | DHR | Danaher CORP | -0.2% | +11.24% | Add |
| 11 | LIN | Linde plc | -0.2% | +3.82% | Add |
| 12 | TXN | Texas Instruments Inc | -1% | -9.23% | Trim |
| 13 | GE | General Electric | -1.2% | -5.50% | Trim |
| 14 | RYAAY | Ryanair Holdings Plc-sp Adr | -1.6% | EXIT | Sold out |
| 15 | SGI | Somnigroup International Inc | -1.9% | EXIT | Sold out |
| 16 | APPF | Appfolio Inc - A | -2.1% | -26.94% | Trim |
| 17 | ✓ | Amphenol Cl A Ord | -3.3% | EXIT | Sold out |
According to official SEC Form 13F filings, Zeno Equity Partners LLP reported a total U.S. public equity portfolio value of $269.0M across 12 disclosed positions in Q4 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including WALDENCAST PLC, DHR, GE) accounted for 74.8% of total reported equity market value during Q4 2024.
Top New Position Initiated
APH
市值: $11.4M
Top Position Liquidated / Trimmed
AMPHENOL CL A ORD
前期市值: $11.7M
During Q4 2024, Zeno Equity Partners LLP's top holdings by market value included WALDENCAST PLC (18.5%)、DHR (12.0%)、GE (10.3%). The largest single position, WALDENCAST PLC, represented 18.5% of total portfolio value.
In Q4 2024, Zeno Equity Partners LLP made 15 total portfolio adjustments, initiating 1 new buys, adding to 5 positions, trimming 4 holdings, and fully liquidating 5 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.